TCIM
ELOX

TIAA CREF Investment Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

TIAA CREF Investment Management’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$497K Buy
1,063
+5
+0.5% +$2.43K ﹤0.01% 2604
2018
Q4 		$508K Sell
1,058
-12
-1% -$6.62K ﹤0.01% 2558
2018
Q3 		$729K Sell
1,070
-124
-10% -$79.4K ﹤0.01% 2565
2018
Q2 		$816K Buy
+1,194
New +$774K ﹤0.01% 2577

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
NEPWA
New England Private Wealth Advisors Wellesley, Massachusetts $866M AUM 15.25% 1-Year Est. Return

TIAA CREF Investment Management's ELOX Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) stake by 0.47% in Q1 2019, buying an estimated $2.43K and bringing the position to 1,063 shares worth $497K. The position accounts for ﹤0.01% of the portfolio, ranked #2604.

TIAA CREF Investment Management first reported a position in ELOX in Q2 2018 and has held it in 4 quarters since. The position peaked at $816K in Q2 2018. 40 funds tracked by Wall St. Rank hold ELOX as of Q1 2019.

  • TIAA CREF Investment Management held 1,063 shares of Eloxx Pharmaceuticals, Inc. Common Stock worth $497K as of Q1 2019.
  • TIAA CREF Investment Management bought 5 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q1 2019, an estimated $2.43K.
  • Eloxx Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2604 holding.
  • TIAA CREF Investment Management first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and has held it in 4 quarters since.
  • TIAA CREF Investment Management's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $816K in Q2 2018.
  • 40 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.